Virus-specific T cells from cryopreserved blood during an emergent virus outbreak for a potential off-the-shelf therapy
Description
CONCLUSION(S): We demonstrated that GMP blood preprocessing and cryopreserving is a successful procedure to obtain an initial cell source able to activate and expand without a specialized antigen presenting agent. Our two-step blood processing
